Form 4 for HIMS Hims & Hers Health, Inc.
Accepted 2026-01-07 00:00:00 ET · period of report 2026-01-05 · accession 0001907056-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-07 | 2026-01-05 | HIMS | Okupe Oluyemi | CFO | S - Sale+OE | $33.79 | -9,070 | 91.6K | -9% | -$306.5K |
| DM | 2026-01-07 | 2026-01-05 | HIMS | Okupe Oluyemi | CFO | M - OptEx | $9.16 | +5,986 | 100.7K | +6% | +$54.8K |
| DM | 2026-01-07 | 2026-01-05 | HIMS | Okupe Oluyemi | CFO | M - OptEx | $0.00 | -5,986 | 156.6K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-01-05 | S | D | 9,070 | $33.79 | 91,617 | D | — | — | (F3) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $33.61-$33.98. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 2 | Common | Class A Common Stock | 2026-01-05 | M | A | 2,178 | $5.01 | 96,879 | D | — | — | (F2) Includes 368 shares acquired on November 20, 2025, under the Hims & Hers Health, Inc. 2020 Employee Stock Purchase Plan. |
| 3 | Common | Class A Common Stock | 2026-01-05 | M | A | 3,808 | $11.53 | 100,687 | D | — | — | |
| 4 | Derivative | Stock Option (right to buy) | 2026-01-05 | M | D | 3,808 | $0.00 | 44,746 | D | $11.53 · — to 2033-03-01 | 3,808 Class A Common Stock | (F5) The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023. |
| 5 | Derivative | Stock Option (right to buy) | 2026-01-05 | M | D | 2,178 | $0.00 | 156,630 | D | $5.01 · — to 2032-02-23 | 2,178 Class A Common Stock | (F4) The Reporting Person received stock options to purchase shares of Class A Common Stock. The stock options vest over a 4-year period, with 1/48 of the shares vesting when the Reporting Person completes each month of continuous service, beginning March 24, 2022. |